Nephrology Doctors in Edison, NJ Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Samir Sutaria, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2177 Oak Tree Rd, Suite 204, Edison, NJ 08820 Phone: 908-686-9330    Fax: 908-769-4736

Satu Mitrakul, MD Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 2177 Oak Tree Rd, Suite 204, Edison, NJ 08820 Phone: 908-686-9330    Fax: 908-769-4736

Namrata Baxi, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 2177 Oak Tree Rd Ste 204, Edison, NJ 08820 Phone: 908-769-4735

Bhavani Prakash Rao, MD Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1819 Oak Tree Rd, Edison, NJ 08820 Phone: 908-757-6655    Fax: 908-757-6653

Jasbir K Kasuri, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 340 Route 1, Redwood Avenue, Edison, NJ 08817 Phone: 732-777-1010    Fax: 732-777-1266

News Archive

ResMed and ATS Foundation award $100,000 to COPD digital health researcher

ResMed and ATS Foundation have awarded their third $100,000 Research Fellowship grant to Claude Farah, PhD, of the Woolcock Institute of Medical Research in Sydney, Australia, to study how remote monitoring can help improve the management of patients with chronic obstructive pulmonary disease, or COPD.

Tomophase to commercialize OCT Imaging System for pulmonary applications with QTDP award

Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced that it has received an award from the Departments of the Treasury and Health and Human Services for the Qualifying Therapeutic Discovery Project (QTDP.)

Could cinnamon modulate the immune response in severe COVID-19?

A new study describes the potential for two common plant products to make a difference in the management of severe COVID-19.

Fero Industries to complete acquisition of Pyro Pharmaceuticals by November 30, 2009

Fero Industries, Inc. is pleased to provide certain disclosures relating to the ten pending patent applications of Pyro Pharmaceuticals, Inc. As previously announced, the Company has initiated the process of acquiring Pyro Pharmaceuticals, Inc. through an exchange of Pyro's capital stock for shares of the Company's common stock, with Fero remaining as the parent entity and Pyro as a subsidiary. The acquisition of Pyro is expected to close by November 30, 2009.

Screening practices for multidrug-resistant organisms in ICUs vary widely between hospitals

Screening practices for multidrug-resistant organisms (MDROs) in intensive care units (ICUs) vary widely from hospital to hospital, according to a new study by researchers at Columbia University School of Nursing and published in the October 2012 issue of the American Journal of Infection Control.

Read more Medical News

› Verified 6 days ago